Cell Therapy's Defining Week: World-First Cancer Treatment, a DMD Landmark, and a Gene-Editing Warning

A 58-year-old ovarian cancer patient just became the first person in the world to receive a new kind of engineered cell therapy. Tracy Tomlinson, diagnosed at stage 3C in 2020 and through 48 chemotherapy infusions, was dosed with ZI-MA4-1 at Manchester's Christie NHS Foundation Trust — an "off-the-shelf" therapy built from donor immune cells engineered to hunt tumours carrying the Mage-A4 protein, found in ovarian, lung, sarcoma and head-and-neck cancers. The trial, led...